Health Technology · Pharmaceuticals: Major · NSE: INNOVACAP · data 2026-10-09

Innova Captab Limited

Health check: Strong (7.7/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹1,110

Market cap

₹6,467 cr

P/E

40.6

P/B

—

ROE

14.0%

ROCE

12.9%

Debt / equity

0.32

Dividend yield

0.18%

1-year return

34.0%

52-week high

₹1,353.5

52-week low

₹622

Operating margin

12.2%

Growth

Revenue (last 12 months)	₹1,749 cr
Net profit (last 12 months)	₹156 cr
Sales growth, 3 years (yearly)	20.1%
Profit growth, 3 years (yearly)	28.2%

Similar companies

Symbiotec Pharmalab Limited (SYMBIOTEC) · Supriya Lifescience Limited (SUPRIYA) · Sanofi India Limited (SANOFI) · Sun Pharma Advanced Research Co. Ltd. (SPARC) · Senores Pharmaceuticals Ltd. (SENORES)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open INNOVACAP in NSE Scanner →